Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Laxmidas Dahyabhai & Co is a prominent Indian pharmaceutical distribution and wholesaling firm specializing in specialty medicines, particularly in the fields of oncology, nephrology, and critical care. Established in 1945 and headquartered in Mumbai, the company serves as a vital link in the healthcare supply chain, providing high-quality pharmaceutical products to hospitals, pharmacies, and patients across India. They are recognized for their expertise in handling cold-chain logistics and sourcing rare or life-saving medications. The company represents numerous multinational and domestic pharmaceutical manufacturers, ensuring the availability of advanced therapeutic options in the Indian market. As a key partner for many global pharmaceutical corporations, the firm plays a crucial role in making advanced treatments accessible within the Indian healthcare ecosystem.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Laxmidas Dahyabhai & Co.